Diagnosis and Allergen Identification of Perioperative Anaphylaxis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorPeking University First Hospital
About this trial
Perioperative anaphylaxis may lead to fatal respiratory and/or circulatory events, yet both clinical diagnosis and management are challenging. Serum tryptase is an indicator that can provide important retrospective diagnostic value for anaphylaxis. Another key point in perioperative anaphylaxis management is to identify the allergens, and thus avoid re-exposure during later perioperative management. Skin testing is an important way to identify allergens.
Eligibility criteria
Qualifiers
Aged 2 years or over;
Suspected anaphylaxis in the operating rooms, or history of suspected anaphylaxis in the operating room.
Disqualifiers
Refuse to participate;
Other conditions that are considered unsuitable for study participation.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
115 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov